Journals / Journal of Istanbul Veterinary Sciences / 2022 / Cilt: 6 - Sayı: 3

Detection of neutralising antibodies against SARS-CoV-2 in companion animals in Istanbul

Pages
128–133
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study is demonstrating the evidence of SARS-CoV-2 infection in dogs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and rapidly spread throughout the world.
📊
Key Findings & Data:After the susceptibility of various animals to SARS-CoV-2 infection was reported, the prevalence of COVID-19 infection in pet animals and their role in virus transmission became a source of concern.
💡
Conclusion & Impact:This study is demonstrating the evidence of SARS-CoV-2 infection in dogs.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:SARS-CoV-2 · SARS-CoV-2 · COVID-19

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and rapidly spread throughout the world. After the susceptibility of various animals to SARS-CoV-2 infection was reported, the prevalence of COVID-19 infection in pet animals and their role in virus transmission became a source of concern. Seroprevalence of SARS-CoV-2 in pet animals has been reported from various parts of the world to date. In this study, 206 serum samples of household dogs and cats were obtained from a diagnostic laboratory in Istanbul. Ninety-nine of the samples were collected during the second wave (November and December 2020) of the pandemic, and 107 were collected between August and September 2021. Neutralizing antibodies against SARS-CoV-2 in companion animals was investigated by virus neutralization test. Among the 99 serum samples which were collected during the second wave (November and December 2020) of the pandemic, while no neutralizing antibodies were found in 61 sera of cats, one of 38 dogs was positive with a titer of 1/256. Similarly, 0/54 cats and 1/53 dogs were tested positive for the neutralizing antibodies among the samples collected between August and September 2021. This study is demonstrating the evidence of SARS-CoV-2 infection in dogs.

🔖

Cite This Article

ENÜL, H., SARAÇ, F., ADIAY, C., UZAR, S., TUNCER-GÖKTUNA, P., ARUN, S. S., HASÖKSÜZ, M. (2022). Detection of neutralising antibodies against SARS-CoV-2 in companion animals in Istanbul. Journal of Istanbul Veterinary Sciences, Cilt: 6 - Sayı: 3, 128–133. https://ajindex.com/articles/860551

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Barua, S., Hoque, M., Adekanmbi, F., Kelly, C., Jenkins-Moore, M., Torchetti, M.K., Chenoweth, K., Wood, T., & Wang, C. (2021) Antibodies to SARS-CoV-2 in dogs and cats, USA. Emerging Microbes and Infections, 10, 1669-1674. DOI: 10.1080/22221751.2021.1967101. Bosco-Lauth, A.M., Hartwig, A.E., Porter, S.M., Gordy, P.W., Nehring, M., Byas, A.D., VandeWoude, S., Ragan, I.K., Maison, R.M., & Bowen R.A. (2020). Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proceedings of the National Academy of Sciences of the United States of America, 117, 26382-26388. DOI:10.1073/pnas.2013102117. Calvet, G.A., Pereira, S.A., Ogrzewalska, M., Pauvolid-Corrêa, A., Resende, P.C., Tassinari, W de S., de Pina Costa, A., Keidel, L.O., da Rocha, A.S.B., da Silva, M.F.B., dos Santos, S.A., Lima, A.B.M., de Moraes, I.C.V., Mendes, A.A.V., das C Souza, T., Martins, E.B., Ornellas, R.O., Corrêa, M.L., da S Antonio, I.M., Guaraldo, L., do C Motta, F., Brasil, P., Siqueira, M.M., Gremião, I.D.F., & Menezes, R.C. (2021). Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil. PLoS One, 16. DOI:10.1371/journal.pone.0250853. Davies, N.G., Abbott, S., Barnard, R.C., Jarvis, C.I., Kucharski, A.J., Munday, J.D., Pearson, C.A.B., Russell, T.W., Tully, D.C., Washburne, A.D., Wenseleers, T., Gimma, A., Waites, W., Wong, K.L.M., van Zandvoort, K., Silverman, J.D., Diaz-Ordaz, K., Keogh, R., Eggo, R.M., Funk, S., Jit, M., Atkins, K.E., & Edmunds, W.J. (2021). Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science, 372. DOI:10.1126/science.abg3055. Fritz, M., Rosolen, B., Krafft, E., Becquart, P., Elguero, E., Vratskikh, O., Denolly, S., Boson, B., Vanhomwegen, J., Gouilh, M.A., Kodjo, A., Chirouze, C., Rosolen, S.G., Legros, V., & Leroy, E.M. (2020). High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health, 11, 100192. DOI:10.1016/J.ONEHLT.2020.100192. Hamer, S.A., Pauvolid-Corrêa, A., Zecca, I.B., Davila, E., Auckland, L.D., Roundy, C.M., Tang, W., Torchetti, M., Killian, M.L., Jenkins-Moore, M., Mozingo, K., Akpalu, Y., Ghai, R.R., Spengler, J.R., Behravesh, C.B., Fischer, R.S.B., & Hamer, G.L. (2020). Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in Texas, USA. bioRxiv. DOI:10.1111/tbed.14122. Lai